PATRYCJA FURGA-NGAKO: Open Payments
NPI 1154197218 · ORO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 44 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $243 |
| Novo Nordisk Inc | 6 | $228 |
| Medtronic, Inc. | 1 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Amgen Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $49 |
| Exact Sciences Corporation | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
Products named: Ozempic, AREXVY, TRELEGY ELLIPTA, INTERSTIM, Rybelsus, AIRSUPRA, CAPLYTA, OTEZLA.
Industry payments across AZ — which companies pay providers there.
